TAKARA BIO INC.
タカラバイオ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4974
FY2024 · 2025-03-31
| Gross margin | 57.9% |
| Operating margin | 5.0% |
| Net margin | 2.3% |
| Return on equity | 1.0% |
| Return on assets | 0.8% |
| Revenue growth (YoY) | 3.5% |
| EPS (basic) | ¥8.65 |
| EPS growth (YoY) | -29.7% |
| Current ratio | 8.09x |
| Equity ratio | 80.0% |
| Book value / share | ¥959.19 |
| Free cash flow | — |